Investing in the
capture layer.
The national identity rails are public infrastructure. The clinical record produced at the point of care is not — and whoever makes that record cheap to produce holds the durable position.
Every competitor is optimising storage and exchange. The unsolved problem is the ninety seconds before either one exists.
Adoption, not features.
This segment has attracted well-funded attempts, including a free offering from the national authority. None achieved sustained use. The accurate claim is not that nobody built it — it is that nobody got clinics to keep using it.
Documentation is a cost the practitioner bears and does not benefit from. At two minutes per patient, software has to be faster than a pad or it is abandoned in week five.
The one artefact the clinic and the patient both already value. Coding is the by-product.
Record exchange has value only where the other clinics a patient visits are also on the platform. Forty per cent of one district beats a fraction of a per cent nationally.
A curated index tuned to how Indian clinicians actually write, built from field observation. It compounds, and it is not something a well-funded entrant can buy.
Gated, not staged.
Each phase has a numeric exit condition agreed in advance. A missed gate returns us to research rather than advancing us to the next build.
Field observation across clinics, a hand-curated concept index, and a live trial on synthetic patients. Exits only if capture is not slower than paper.
Full offline client, prescription output, patient search and recall. No ecosystem integration until clinics are retaining.
ABHA, registry onboarding, FHIR record exchange, data-protection implementation and independent security assessment — before any real patient data.
Concentrate rather than spread. Exchange becomes useful, and unit economics become measurable rather than estimated.
The retention metric that governs progression is measured with no support contact for twenty-one days, by someone other than the person who onboarded the clinic.
Numbers we do not have.
We have no independently validated outcome figures, no certification, and no sustained adoption at scale yet. Anything presented as achieved will be evidenced.
Request the data room.
Detailed materials and current status available to qualified investors under NDA.